Table 2.
Intraoperative and postoperative outcomes in patients undergoing laparoscopic vs. robot-assisted LESS donor nephrectomy
| Type of donor surgery | |||
|---|---|---|---|
|
|
|||
| Laparoscopic | R-LESS | p | |
| Number of patients | 25 | 14 | - |
| Operative time (min) | 240±53 | 269±75 | 0.90 |
| Estimated blood loss (mL) | 103±70 | 140±59 | 0.24 |
| Length of stay (days) | 3.5±0.86 | 3.1±0.70 | 0.81 |
| WIT (min) | 4.15±1.1 | 4.3±1.1 | 0.52 |
| Total hydromorphone equivalent (mg) | 18.15±5.1 | 15.9±3.3 | 0.002 |
| Serum creatinine (μmol/L, day 3) | 96±10 | 95±15 | 0.51 |
| Serum creatinine (μmol/L, 1 year) | 102±21 | 106±12 | 0.22 |
| eGFR (mL/min per 1.73 m2) | 84±17.14 | 86±17.74 | 0.51 |
| DGF | 0 | 0 | - |
| Complications: (Clavien-Dindo) | |||
| Hematoma requiring transfusion | 0 | 1 | - |
| Abdominal wall hematoma no transfusion | 1 | 0 | - |
| Neuromuscular pain | 2 | 0 | - |
| Port site infection | 1 | 0 | - |
All complications classified as Grade 2 according to the Clavien-Dindo system. Data are presented as mean ± standard deviation. DGF: delayed graft function; eGFR: estimated glomerular filtration rate; R-LESS: robotic laparoendoscopic single-site; WIT: warm ischemic time.